GRDN Earnings Date: Nov 5, 2026 (Estimated) — Guardian Pharmacy Services, Inc.
NYSE · Healthcare · Medical Care Facilities
Updated
When is GRDN's next earnings date?
Guardian Pharmacy Services, Inc. (GRDN) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.31 on revenue of $365.8M.
How did GRDN do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Guardian Pharmacy Services, Inc. posted EPS of $0.29 versus the $0.26 estimate, a beat of 11.5%. Revenue was $351.8M against a $340.4M estimate. The stock's 1-day post-earnings move was +11.0%.
How much does GRDN stock move after earnings?
GRDN beat EPS estimates in 5 of its last 6 reported quarters. Over the last 6 reports the stock moved an average of 6.0% (up or down) in the day after earnings.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 0.26 | 0.29 | +11.54% | $351.8M | ✅ Beat | +11.05% | -2.56% | +3.29% |
| 2026-05-06 | Q1 2026 | 0.24 | 0.29 | +20.83% | $336.6M | ✅ Beat | -0.85% | -2.49% | +10.66% |
| 2026-03-11 | Q4 2025 | 0.26 | 0.37 | +42.31% | $397.6M | ✅ Beat | -0.72% | +1.19% | +16.83% |
| 2025-11-10 | Q3 2025 | 0.22 | 0.25 | +13.64% | $377.4M | ✅ Beat | +5.04% | -4.77% | +0.57% |
| 2025-08-11 | Q2 2025 | 0.20 | 0.23 | +15.00% | $344.3M | ✅ Beat | +13.78% | +24.85% | +45.77% |
| 2025-03-26 | Q4 2024 | 0.22 | 0.19 | -13.64% | $338.6M | ❌ Miss | +4.35% | +6.43% | +19.62% |
| 2022-06-30 | — | -0.10 | — | $224.1M | — | — | — | — | |
| 2022-03-31 | — | 0.30 | — | $211.0M | — | — | — | — |
Showing last 8 quarters.